ZHENG M.Classification and pathology of lung cancer[J].Surg Oncol Clin N Am,2016,25(3):447-468.
 ZHOU H H,LIU L Y,YU G H,et al. Analysis of clinicopathological features and prognostic factors in 39 cases of bladder neuroendocrine carcinoma[J].Anticancer Res,2017,37(8):4529-4537.
 CHEN F,ZHANG Y,PARRA E,et al.Multiplatform-based molecular subtypes of non-small-cell lung cancer[J].Oncogene,2017,36(10):1384-1393.
 HUANG Z,XU D,ZHANG F,et al.Pro-gastrin-releasing peptide and neuron-specific enolase:useful predictors of response to chemotherapy and survival in patients with small cell lung cancer[J].Clin Transl Oncol,2016,18(10):1019-1025.
 INOMATA M,HAYASHI R,YAMAMOTO A,et al.Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib[J].Mol Clin Oncol,2015,3(4):802-806.
 WANG H, QIAN J.Serum pro-gastrin-releasing peptide in diagnosis of small cell lung cancer:a meta-analysis[J].J Cancer Res Ther,2016,12(Supplement):260-263.
 NISMAN B,NECHUSHTAN H,BIRAN H,et al.New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer[J].Br J Cancer,2016,114(4):469-476.
 WALDMANN T A.JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma:inspired by functional and structural genomics[J].Mol Cell Endocrinol,2017,15(451):66-70.
 QUICK L,YOUNG R,HENRICH I C,et al.Jak1-STAT3 signals are essential effectors of the USP6/TRE17 oncogene in tumorigenesis[J].Cancer Res,2016,76(18):5337-5347.
 GU Y J,SUN W Y,ZHANG S,et al.Targeted blockade of JAK/STAT3 signaling inhibits proliferation, migration and collagen production as well as inducing the apoptosis of hepatic stellate cells[J].Int J Mol Med,2016,38(3):903-911.
 CHANG S H,HWANG C S,YIN J H,et al.Oncostatin M-dependent Mcl-1 induction mediated by JAK1/2-STAT1/3 and CREB contributes to bioenergetic improvements and protective effects against mitochondrial dysfunction in cortical neurons[J].Biochim Biophys Acta,2015,1853(10 Pt A):2306-2325.
 XU G Y,TANG X J.Troxerutin (TXN) potentiated 5-fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways[J].Biomed Pharmacother,2017,92:95-107.
 XIANG Y, YE W,HUANG C,et al.Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling pathway[J].Biochem Biophys Res Commun,2017,487(4):820-826.
 KIARTIVICH S,WEI Y,LIU J,et al. Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells[J].Oncol Lett,2017,13(4):2799-2804
 INOUE-YAMAUCHI A,JENG P S,KIM K,et al.Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy[J].Nat Commun,2017,17(8):16078.
 LI R,DING C,ZHANG J,et al.Modulation of Bax and mTOR for cancer therapeutics[J].Cancer Res,2017,77(11):3001-3012.